Stem cell grant OKd for L.A. center linked to allegations
By Mary Engel,
Los Angeles Times
| 03. 27. 2007
California's voter-created stem cell institute approved a $2.6-million grant earlier this month to a Los Angeles-based research center whose founding president, a South Korean fertility expert, is embroiled in an international dispute over authorship of a medical journal article.
In addition, the medical director of an associated fertility clinic in the same location faces allegations of having an improper sexual relationship with a patient and lying to her about the number of eggs he had collected from her. The clinic and the research center are owned by the same parent company.
Critics of the closed-door grant reviews arranged by the California Institute for Regenerative Medicine say the decision is a reason to open the process more to public scrutiny. "Had everyone known that a grant was being discussed to that organization, things would have gone slower and questions would have been raised then," said John Simpson of the Foundation for Taxpayer and Consumer Rights in Santa Monica.
The CHA Regenerative Medicine Institute in L.A. applied for the grant to try to develop a line of human embryonic stem cells that...
Related Articles
By Courtney Withers and Daryna Zadvirna, ABC News | 12.03.2025
Same-sex couples, single people, transgender and intersex West Australians will be able to access assisted reproductive technology (ART) and surrogacy, almost a decade after reforms were first promised.
The landmark legislation, which removes the requirement for people to demonstrate medical...
By Rachel Hall, The Guardian | 11.20.2025
Couples are needlessly going through IVF because male infertility is under-researched, with the NHS too often failing to diagnose treatable causes, leading experts have said.
Poor understanding among GPs and a lack of specialists and NHS testing means male infertility...
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
